Global Companion Diagnostics Market to Grow to US$5.6 bn by 2019, Propelled by Increasing Need for Higher Drug Efficacy
Companion diagnostics are used by physicians to make precise decisions regarding specific drug treatments by considering the patient's response during every stage of the treatment. Companion diagnostics indicate adverse reactions and favorable reactions to a specific line of treatment and also assist in optimizing dosage of drugs.
View full press release